publication date: Jul. 24, 2020

Clinical Roundup

UArizona Health Sciences’ portable device may change standard of care for skin cancer

Researchers at the University of Arizona Health Sciences have developed a handheld device to bring skin cancer prevention and treatment options into more patient-care settings.

The device, a portable confocal microscope, is a modernized and more practical use of reflective confocal microscopy—technology that provides non-invasive imaging of the skin.

In RCM, the microscope directs a narrow laser light on a specific spot on the skin with vertical and horizontal scanning capability. This results in a real-time diagnosis that, in some cases, can bypass the need for a biopsy and lead to same-day treatment for malignant lesions.

Clara Curiel-Lewandrowski, the Alan and Janice Levin Family Endowed Chair for Excellence in Cancer Research, co-director of the Skin Cancer Institute at the UArizona Cancer Center, and professor and interim chief of the Division of Dermatology, College of Medicine–Tucson, brought the technology to the university. Curiel purchased a commercial instrument for her clinical practice in 2014 with funding from the UArizona Technology and Research Initiative Fund Dr.

“The commercial instrument we purchased has three lasers, which allows us to expand into studies evaluating fluorescent properties,” Curiel said in a statement. “One of the benefits of having our own instrument is that other investigators can compare their imaging technology to an industry gold standard, holding FDA approval for skin assessment. That provides us the capability to provide feedback to the investigators and improve the technology.”

Dongkyun Kang, co-leader of the Cancer Imaging Program, an assistant professor of optical sciences and biomedical engineering, BIO5 Institute member, has a lab focused on lowering manufacturing costs by developing the PCM … Continue reading UArizona Health Sciences’ portable device may change standard of care for skin cancer

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.